PROM1 and colonic neoplasm: CD133/prominin-1, a pentaspan transmembrane glycoprotein, has been initially described as a surface antigen specially to human hematopoietic stem cells [16] and CSCs with CD 133 positivity have been implicated in tumor progress as identified in tumor growth of pancreatic [11] and colon cancers [4].